We'd love to hear from you. Whether you're interested in learning more about our technology, exploring partnership opportunities, or joining our team, please don't hesitate to reach out.
NeXell's technology equips immune cells with built-in intelligence and multi-level auto-switches, enabling them to self-regulate and dynamically adjust their activity in response to the diverse and evolving nature of cancers. This approach addresses key limitations of current cell therapies, including limited efficacy in solid tumors, safety concerns, and short durability.
Yes, we're open to strategic partnerships that can help advance our mission of developing smarter, safer, and more effective immune cell therapies. Our de-risked business model offers multiple paths to value creation, including strategic partnerships with leading CAR-T developers. If you're interested in exploring partnership opportunities, please contact us using the form above.
While current CAR-T therapies have shown remarkable success in blood cancers, our technology is designed to address both blood cancers and solid tumors. Solid tumors account for more than 90% of all cancer cases and represent a significant unmet medical need. Our platform is uniquely positioned to overcome the challenges associated with treating solid tumors.
We're always looking for talented individuals who are passionate about revolutionizing cancer treatment through innovative cell therapies. We're growing our team across multiple functions, including Cell Therapy Research, Synthetic Biology, Immunology, Process Development, and Bioinformatics. If you're interested in joining our team, please reach out using the contact form above.
Join us in our mission to develop smarter, safer, and more effective immune cell therapies.